No Data
Cytek Biosciences, Inc. (NASDAQ:CTKB) CFO Patrik Jeanmonod Sells 3,500 Shares
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CFO Patrik Jeanmonod sold 3,500 shares of the business's stock in a transaction on Monday, September 26th. The stock was sold at an average price of
Cytek Biosciences (NASDAQ:CTKB) Shares Up 8.3%
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) shot up 8.3% during mid-day trading on Wednesday . The company traded as high as $13.80 and last traded at $13.80. 5,581 shares were traded during
Walleye Capital LLC Buys 32,032 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB)
Walleye Capital LLC raised its stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) by 48.7% during the first quarter, according to its most recent filing with the Securities and Exchange Com
RA Capital Management L.P. Grows Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB)
RA Capital Management L.P. increased its holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) by 39.3% during the first quarter, according to its most recent filing with the Securities and
Healthcare of Ontario Pension Plan Trust Fund Buys Shares of 126,800 Cytek Biosciences, Inc. (NASDAQ:CTKB)
Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) during the 1st quarter, according to its most recent filing with the Securit
Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Significant Decrease in Short Interest
Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) saw a significant drop in short interest in August. As of August 15th, there was short interest totalling 2,760,000 shares, a drop of 12.1% from th
Reviewing PositiveID (OTCMKTS:PSID) and Cytek Biosciences (NASDAQ:CTKB)
PositiveID (OTCMKTS:PSID – Get Rating) and Cytek Biosciences (NASDAQ:CTKB – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the stre
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare Conference
FREMONT, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (NASDAQ:CTKB), today announced the company will be participating in the upcoming 20th Annual Morgan Stanley Global Healthcare Conference in New
Olink Holding AB (Publ) (NASDAQ:OLK) and Cytek Biosciences (NASDAQ:CTKB) Head-To-Head Survey
Cytek Biosciences (NASDAQ:CTKB – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two compa
Update: Cytek Biosciences Files for Mixed-Securities Shelf Offering -- Shares Fall Monday
01:30 PM EDT, 08/29/2022 (MT Newswires) -- (Updates with share price movement in the headline and last paragraph.) Cytek Biosciences (CTKB) registered with the US Securities and Exchange Commission a
Loading...
